Literature DB >> 27780966

Isolation and identification of new macrocyclic lactones from a genetically engineered strain Streptomyces bingchenggensis BCJ60.

Jiansong Li1, Shaoyong Zhang2, Hui Zhang3, Haiyan Wang1, Ji Zhang1, Anliang Chen2, Jidong Wang2,3, Wensheng Xiang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27780966     DOI： 10.1038/ja.2016.130

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  14 in total

1.  Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.

Authors:  Aili Gao; Xiangjing Wang; Wensheng Xiang; Hongsheng Liang; Jiguo Gao; Yijun Yan
Journal:  J Pharm Pharmacol       Date:  2010-03       Impact factor: 3.765

2.  Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties.

Authors:  T W Miller; L Chaiet; D J Cole; L J Cole; J E Flor; R T Goegelman; V P Gullo; H Joshua; A J Kempf; W R Krellwitz; R L Monaghan; R E Ormond; K E Wilson; G Albers-Schönberg; I Putter
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

3.  Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains.

Authors:  Leah E Lim; Catherine Vilchèze; Carol Ng; William R Jacobs; Santiago Ramón-García; Charles J Thompson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-19       Impact factor: 5.191

4.  Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.

Authors:  Wensheng Xiang; Aili Gao; Hongsheng Liang; Changyu Li; Jiguo Gao; Qing Wang; Bao Shuang; Ji Zhang; Yijun Yan; Xiangjing Wang
Journal:  Toxicol In Vitro       Date:  2010-07-23       Impact factor: 3.500

5.  Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties.

Authors:  Y Takiguchi; H Mishima; M Okuda; M Terao; A Aoki; R Fukuda
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

6.  Three new milbemycins from a genetically engineered strain S. avermitilis MHJ1011.

Authors:  Jun-jie Pan; Xu Wan; Hui Zhang; Zhen Chen; Jun Huang; Bo Yang; An-liang Chen; Ji-dong Wang
Journal:  J Antibiot (Tokyo)       Date:  2015-09-02       Impact factor: 2.649

7.  Combined application of plasma mutagenesis and gene engineering leads to 5-oxomilbemycins A3/A4 as main components from Streptomyces bingchenggensis.

Authors:  Hai-Yan Wang; Ji Zhang; Yue-Jing Zhang; Bo Zhang; Chong-Xi Liu; Hai-Rong He; Xiang-Jing Wang; Wen-Sheng Xiang
Journal:  Appl Microbiol Biotechnol       Date:  2014-08-02       Impact factor: 4.813

Review 8.  Ivermectin.

Authors:  George W Elgart; Terri L Meinking
Journal:  Dermatol Clin       Date:  2003-04       Impact factor: 3.478

9.  Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons.

Authors:  Thomas R Hoye; Christopher S Jeffrey; Feng Shao
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

10.  Designed biosynthesis of 25-methyl and 25-ethyl ivermectin with enhanced insecticidal activity by domain swap of avermectin polyketide synthase.

Authors:  Ji Zhang; Yi-Jun Yan; Jing An; Sheng-Xiong Huang; Xiang-Jing Wang; Wen-Sheng Xiang
Journal:  Microb Cell Fact       Date:  2015-09-24       Impact factor: 5.328
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.